160 related articles for article (PubMed ID: 2541502)
1. AP1/jun function is differentially induced in promotion-sensitive and resistant JB6 cells.
Bernstein LR; Colburn NH
Science; 1989 May; 244(4904):566-9. PubMed ID: 2541502
[TBL] [Abstract][Full Text] [Related]
2. Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells.
Dong Z; Birrer MJ; Watts RG; Matrisian LM; Colburn NH
Proc Natl Acad Sci U S A; 1994 Jan; 91(2):609-13. PubMed ID: 8290571
[TBL] [Abstract][Full Text] [Related]
3. bcl-2 enhancement of malignant transformation in mouse epidermal JB6 cells.
Amstad PA; Liu H; Ichimiya M; Chang S; Berezesky IK; Trump BF
Mol Carcinog; 1997 Oct; 20(2):231-9. PubMed ID: 9364213
[TBL] [Abstract][Full Text] [Related]
4. Differential c-jun expression in response to tumor promoters in JB6 cells sensitive or resistant to neoplastic transformation.
Ben-Ari ET; Bernstein LR; Colburn NH
Mol Carcinog; 1992; 5(1):62-74. PubMed ID: 1543542
[TBL] [Abstract][Full Text] [Related]
5. Gene regulation and genetic susceptibility to neoplastic transformation: AP-1 and p80 expression in JB6 cells.
Bernstein LR; Ben-Ari ET; Simek SL; Colburn NH
Environ Health Perspect; 1991 Jun; 93():111-9. PubMed ID: 1773784
[TBL] [Abstract][Full Text] [Related]
6. Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation.
Dhar A; Hu J; Reeves R; Resar LM; Colburn NH
Oncogene; 2004 May; 23(25):4466-76. PubMed ID: 15064752
[TBL] [Abstract][Full Text] [Related]
7. [The c-fos proto-oncogene promotor is not regulated by serum, epidermal growth factor, and phorbol ester in embryonal fibroblasts transformed by E1Aad5+cHa-ras-oncogenes].
Pospelova TV; Medvedev AV; Kisliakova TV; Svetlikova SB; Pospelov VA
Mol Biol (Mosk); 1991; 25(1):105-15. PubMed ID: 1716733
[TBL] [Abstract][Full Text] [Related]
8. c-jun and multistage carcinogenesis: association of overexpression of introduced c-jun with progression toward a neoplastic endpoint in mouse JB6 cells sensitive to tumor promoter-induced transformation.
Watts RG; Ben-Ari ET; Bernstein LR; Birrer MJ; Winterstein D; Wendel E; Colburn NH
Mol Carcinog; 1995 May; 13(1):27-36. PubMed ID: 7766308
[TBL] [Abstract][Full Text] [Related]
9. Involvement of protein kinase C in the transcriptional regulation of 12-O-tetradecanoylphorbol-13-acetate-inducible genes modulated by AP-1 or non-AP-1 transacting factors.
Tseng CP; Kim YJ; Kumar R; Verma AK
Carcinogenesis; 1994 Apr; 15(4):707-11. PubMed ID: 8149484
[TBL] [Abstract][Full Text] [Related]
10. Transformation nonresponsive cells owe their resistance to lack of p65/nuclear factor-kappaB activation.
Hsu TC; Nair R; Tulsian P; Camalier CE; Hegamyer GA; Young MR; Colburn NH
Cancer Res; 2001 May; 61(10):4160-8. PubMed ID: 11358840
[TBL] [Abstract][Full Text] [Related]
11. Regulation of human glutathione S-transferase pi gene transcription: influence of 5'-flanking sequences and trans-activating factors which recognize AP-1-binding sites.
Morrow CS; Goldsmith ME; Cowan KH
Gene; 1990 Apr; 88(2):215-25. PubMed ID: 2112105
[TBL] [Abstract][Full Text] [Related]
12. 12-O-tetradecanoylphorbol-13-acetate--induced levels of AP-1 proteins: a 46-kDa protein immunoprecipitated by anti-fra-1 and induced in promotion-resistant but not promotion-sensitive JB6 cells.
Bernstein LR; Bravo R; Colburn NH
Mol Carcinog; 1992; 6(3):221-9. PubMed ID: 1445622
[TBL] [Abstract][Full Text] [Related]
13. Tumor promoter-induced ornithine decarboxylase gene expression occurs independently of AP-1 activation.
Jansen AP; Colburn NH; Verma AK
Oncogene; 1999 Oct; 18(42):5806-13. PubMed ID: 10523861
[TBL] [Abstract][Full Text] [Related]
14. EGF-induced jun B-expression in transfected P19 embryonal carcinoma cells expressing EGF-receptors is dependent on Jun D.
den Hertog J; de Groot RP; de Laat SW; Kruijer W
Nucleic Acids Res; 1992 Jan; 20(1):125-30. PubMed ID: 1738590
[TBL] [Abstract][Full Text] [Related]
15. SAG/ROC2/Rbx2 is a novel activator protein-1 target that promotes c-Jun degradation and inhibits 12-O-tetradecanoylphorbol-13-acetate-induced neoplastic transformation.
Gu Q; Tan M; Sun Y
Cancer Res; 2007 Apr; 67(8):3616-25. PubMed ID: 17440073
[TBL] [Abstract][Full Text] [Related]
16. Effect of curcumin on 12-O-tetradecanoylphorbol-13-acetate- and ultraviolet B light-induced expression of c-Jun and c-Fos in JB6 cells and in mouse epidermis.
Lu YP; Chang RL; Lou YR; Huang MT; Newmark HL; Reuhl KR; Conney AH
Carcinogenesis; 1994 Oct; 15(10):2363-70. PubMed ID: 7955078
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element.
Li JJ; Dong Z; Dawson MI; Colburn NH
Cancer Res; 1996 Feb; 56(3):483-9. PubMed ID: 8564958
[TBL] [Abstract][Full Text] [Related]
18. Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells.
Huang C; Ma WY; Young MR; Colburn N; Dong Z
Proc Natl Acad Sci U S A; 1998 Jan; 95(1):156-61. PubMed ID: 9419345
[TBL] [Abstract][Full Text] [Related]
19. The role of glycogen synthase kinase 3beta in the transformation of epidermal cells.
Ma C; Wang J; Gao Y; Gao TW; Chen G; Bower KA; Odetallah M; Ding M; Ke Z; Luo J
Cancer Res; 2007 Aug; 67(16):7756-64. PubMed ID: 17699780
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of both nuclear factor-kappaB and activator protein-1 activation block the neoplastic transformation response.
Li JJ; Westergaard C; Ghosh P; Colburn NH
Cancer Res; 1997 Aug; 57(16):3569-76. PubMed ID: 9270030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]